{"title":"Maker of weight-loss drugs to ask Trump to pause price negotiations: Report","link":"https://arstechnica.com/health/2025/01/maker-of-weight-loss-drugs-to-ask-trump-to-pause-price-negotiations-report/","date":1736893577000,"content":"<p>Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price negotiations that were put in place by the Biden administration's Inflation Reduction Act (IRA).</p>\n<p>\"They need to fix [the IRA],\" <a href=\"https://www.bloomberg.com/news/articles/2025-01-13/lilly-asks-biden-administration-to-pause-drug-price-negotiations\">Eli Lilly CEO Dave Ricks told Bloomberg</a> at the JPMorgan Healthcare Conference in San Francisco.</p>\n<p><a href=\"https://arstechnica.com/science/2024/08/big-name-drugs-see-price-drops-in-first-round-of-medicare-negotiations/\">The results of the first round of IRA negotiations</a>, announced in August, saw the list prices of 10 high-cost drugs get slashed by as much as 79 percent. Collectively, the negotiated prices are estimated to save seniors $1.5 billion in out-of-pocket costs in 2026, when the prices go into effect. The savings will likely be well received, given that KFF polling has found that <a href=\"https://www.kff.org/health-costs/poll-finding/public-opinion-on-prescription-drugs-and-their-prices/\">over a quarter of Americans struggle to afford prescription medications</a>, and 31 percent say they haven't taken medicines as prescribed due to costs.</p><p><a href=\"https://arstechnica.com/health/2025/01/maker-of-weight-loss-drugs-to-ask-trump-to-pause-price-negotiations-report/\">Read full article</a></p>\n<p><a href=\"https://arstechnica.com/health/2025/01/maker-of-weight-loss-drugs-to-ask-trump-to-pause-price-negotiations-report/#comments\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"b5cccc74ac1577ffab94f6b527798bd3592d580695f22e2c2e907b134aa7381b","category":"Tech"}